Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05644457

Exploratory Study of Early Biomarkers Allowing Dynamic Assessment of Response to Treatment in Cancers of the Head and Neck

Conditions: Head and Neck Cancer

Sex: All

Ages: 18 Years – N/A

Enrollment: 50

Sponsor: Royal Marsden NHS Foundation Trust

Location: United Kingdom

Summary

DART is an exploratory molecular analysis study to assess potential early biomarkers of treatment response in squamous cell carcinoma of the head and neck (HNSCC)

Eligibility Criteria

Inclusion Criteria:Age 18 years or olderPatients with histologically confirmed cancer of the head and neck with evidence of recurrent or locally advanced cancer not suitable for treatment with curative intent, or metastatic disease.Receiving immunotherapyAbility to give informed consent for biological sample collection.Exclusion Criteria:Unable to undergo serial sample collectionPregnancy

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05644457). StuddyBuddy aggregates publicly available trial information.